The document is an IPO prospectus for a company identified as an 'emerging growth company' under federal securities laws. It outlines the initial public offering price, underwriting discounts, commissions, and proceeds before expenses. The underwriters have a 30-day option to purchase additional shares. The document also mentions the risks involved in investing in the company's common stock and states that neither the SEC nor any regulatory body has approved the securities. The underwriters include J.P. Morgan, Allen & Company LLC, BofA Merrill Lynch, and others.
documents/EFTA01377963.pdf
{}